The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
The AESGP is a non-profit organization that represents the manufacturers of non-prescription medicines, food supplements, and self-care medical devices in Europe; here, they explore the importance of self-care policies, supported by evidence on their economic, social, and health benefits.
Polygenic risk scores, used to estimate an individual's genetic risk for common diseases, including heart disease, need to catch up in their predictive capabilities, as highlighted by a recent study led by UCL researchers.
In a recent study, researchers from Brigham and Women's Hospital investigated the connection between men's antidepressant use, anxiety and depression and their impact on in vitro fertilisation (IVF) outcomes.
Michael Wong, Founder and Executive Director at Physician-Patient Alliance for Health & Safety and Amy Campbell, Quality Nurse Specialist at ECU Health and Chair at PPAHS Sepsis Advisory Board, discuss how the COVID-19 pandemic has impacted the fight against sepsis.
Decoding pathogens’ genetic material is fast becoming an invaluable tool to support pandemic preparedness and responses to global public health threats, Anona Bamford tells us more
SARMs and CBD: Navigating Regulatory Gaps in UK's Food Industry - Unusual products blur the lines between food and medicine, prompting questions about effective regulation.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director, shares insights from a patient survey on reducing the carbon footprint of medicines.
In an era marked by technological leaps and a shift towards patient-centred care, a virtual ward has emerged as a pioneering solution that bridges the gap between traditional hospital setups and the convenience of remote healthcare.
